-
IGXT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
-
Shorts
IntelGenx Technologies (IGXT)
Company Profile
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 772.00 k | 772.00 k | 772.00 k | 772.00 k | 772.00 k | 772.00 k |
Cash burn (monthly) | 503.33 k | 145.67 k | 1.08 mm | 842.25 k | 952.00 k | 593.25 k |
Cash used (since last report) | 5.58 mm | 1.62 mm | 11.96 mm | 9.34 mm | 10.56 mm | 6.58 mm |
Cash remaining | -4.81 mm | -843.61 k | -11.19 mm | -8.57 mm | -9.79 mm | -5.81 mm |
Runway (months of cash) | -9.6 | -5.8 | -10.4 | -10.2 | -10.3 | -9.8 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 39.84 mm |
Total shares | 257.68 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
ATAI Atai Life Sciences | 257.68 mm | $39.84 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jan 24 | Karen Kalayajian | Restricted Share Units (p.v.0.00001 ) Common Stock | Grant | Acquire A | No | No | 0 | 97,925 | 0.00 | 137,925 |
29 Jan 24 | Karen Kalayajian | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 508,750 |
29 Jan 24 | Karen Kalayajian | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 465,000 |
29 Jan 24 | Karen Kalayajian | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 415,000 |
29 Jan 24 | Karen Kalayajian | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 371,250 |
29 Jan 24 | Bernd Josef Melchers | Restricted Share Units (p.v.0.00001) Common Stock | Grant | Acquire A | No | No | 0 | 111,783 | 0.00 | 111,783 |
29 Jan 24 | Nadine Paiement | Restricted Share Units (p.v.0.00001 ) Common Stock | Grant | Acquire A | No | No | 0 | 96,206 | 0.00 | 136,206 |
29 Jan 24 | Nadine Paiement | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 434,970 |
29 Jan 24 | Nadine Paiement | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 391,220 |
29 Jan 24 | Nadine Paiement | Options (right to buy) p.v.0.00001 Common Stock | Grant | Acquire A | No | No | 0.14 | 37,500 | 5.25 k | 353,720 |